Megan Lyle - Concepedia

Author

Megan Lyle

The University of Sydney

Also Known As

Lyle, M., M. Lyle, Megan Kate Lyle, Megan Lyle

Publications

681

Citations

H-Index

Concepts

All Affiliations

The University of Sydney Melanoma Institute Australia Royal North Shore Hospital Cairns Hospital Westmead Hospital

About

Megan Lyle is an author at The University of Sydney specializing in medicine, cancer therapeutics, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	393
2	Immunology	5	5	290
3	Health Sciences	2	2	36
4	Pathology	2	2	98
5	Cell Biology	1	1	77

Megan Lyle

Publications

626

Citations

H-Index

Page 1

	Year	Citations
Ipilimumab alone or ipilimumab plus anti-PD-1 therapy in patients with metastatic melanoma resistant to anti-PD-(L)1 monotherapy: a multicentre, retrospective, cohort study Inês Pires da Silva, Tasnia Ahmed, Irene L. M. Reijers, The Lancet Oncology OncologyAnti-pd-1 TherapyMelanomaImmunologyClinical Trials	2021	201
Activity of trametinib in K601E and L597Q BRAF mutation-positive metastatic melanoma Samantha Bowyer, Aparna D. Rao, Megan Lyle, Melanoma Research OncologyMedicineBraf K601eMelanomaTrametinib Toxicity	2014	77
The nature and management of metastatic melanoma after progression on <scp>BRAF</scp> inhibitors: Effects of extended <scp>BRAF</scp> inhibition Matthew Chan, Lauren E. Haydu, Alexander M. Menzies, Cancer	2014	72
Clinicopathologic features associated with efficacy and long‐term survival in metastatic melanoma patients treated with <scp>BRAF</scp> or combined <scp>BRAF</scp> and MEK inhibitors Alexander M. Menzies, James S. Wilmott, Martin Drummond, Cancer	2015	49
Metastasis‐specific patterns of response and progression with anti‐<scp>PD</scp>‐1 treatment in metastatic melanoma Jenny Lee, Megan Lyle, Alexander M. Menzies, Pigment Cell & Melanoma Research	2017	44
Enhancing Chemotherapy Capabilities in Rural Hospitals: Implementation of a Telechemotherapy Model (QReCS) in North Queensland, Australia Sabe Sabesan, Clare Senko, Andrew Schmidt, Journal of Oncology Practice	2018	35
Diagnosis and Treatment of <i>KIT</i>-Mutant Metastatic Melanoma Megan Lyle, Georgina V. Long Journal of Clinical Oncology	2013	33
Ipilimumab (IPI) alone or in combination with anti-PD-1 (IPI+PD1) in patients (pts) with metastatic melanoma (MM) resistant to PD1 monotherapy. Inês Pires da Silva, Tasnia Ahmed, Serigne Lo, Journal of Clinical Oncology Disease ProgressionImmunodeficienciesPrognosisImmunologyPharmacotherapy	2020	31
The molecular profile of metastatic melanoma in Australia Megan Lyle, Lauren E. Haydu, Alexander M. Menzies, Pathology MelanomaMolecular ProfileDermatologyMedicineTumor Microenvironment	2016	26
Durability of response to immune checkpoint inhibitors in metastatic Merkel cell carcinoma after treatment cessation Alison M. Weppler, Laetitia Da Meda, Inês Pires da Silva, European Journal of Cancer Cancer ImmunosurveillanceCheckpoint InhibitorsMedicineImmunologyImmune Checkpoint Inhibitor	2023	22

Page 1